Biologics have blossomed in recent years as a lucrative market for contract manufacturers, with drugmakers dropping big bucks in the field. A California CDMO is hoping to splash into the fray in a big way, and it's plotting a major facility in Switzerland to tap the Euro large-molecule market.
Sunnyvale-based CDMO JSR Life Sciences will add 250 jobs at a new double-occupant campus in Geneva that will house operations for the company's KBI Biopharma and Selexis SA affiliates, JSR said this week.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,